JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikonen, T.
Right arrow Articles by Jänne, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikonen, T.
Right arrow Articles by Jänne, O. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 47, Issue of November 21, 1997 pp. 29821-29828
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Interaction between the Amino- and Carboxyl-terminal Regions of the Rat Androgen Receptor Modulates Transcriptional Activity and Is Influenced by Nuclear Receptor Coactivators

(Received for publication, July 10, 1997, and in revised form, September 11, 1997)

Tarja Ikonen Dagger , Jorma J. Palvimo Dagger and Olli A. Jänne Dagger §

From the Dagger  Department of Physiology, Institute of Biomedicine and the § Department of Clinical Chemistry, University of Helsinki, FIN-00014 Helsinki, Finland

Identical N-terminal deletions in the wild-type rat androgen receptor (rAR) and a constitutively active rAR (ARDelta 641-902) devoid of the ligand-binding domain (LBD) resulted in dissimilar consequences in transcriptional activation: deletion of residues 149-295 abolished wild-type AR activity, but did not influence that of ARDelta 641-902. The activity of the N-terminal transactivation domain is thus controlled by the hormone-occupied LBD, suggesting that the N- and C-terminal regions of rAR communicate. Consistent with this idea, a strong androgen-dependent interaction between the N-terminal region and LBD was demonstrated in a mammalian two-hybrid system using GAL4 and VP16 fusion proteins. This interaction can be direct or indirect. Several nuclear receptor coactivators (CBP, F-SRC-1, SRC-1, and RIP140) that interact with other steroid receptors were tested as potential mediators of the N- and C-terminal interaction of rAR using the mammalian two-hybrid system. CBP or F-SRC-1 not only enhanced AR-mediated transactivation, but also facilitated the androgen-dependent interaction between the N- and C-terminal domains, implying that part of the coactivator-dependent transcriptional activation occurs via this mechanism. In contrast, SRC-1, a coactivator for the progesterone receptor, inhibited both AR-mediated transactivation and interaction between the N and C termini. Recruitment of coregulators may involve AR domains other than the LBD, as F-SRC-1 and CBP enhanced, but SRC-1 repressed, the transcriptional activity of ARDelta 641-902. Collectively, interplay between the N-terminal region and LBD of rAR results in the formation of a transactivation complex that includes coregulators and that is mandatory for optimal activation of androgen-induced promoters.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. M. Dehm, L. J. Schmidt, H. V. Heemers, R. L. Vessella, and D. J. Tindall
Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
Cancer Res., July 1, 2008; 68(13): 5469 - 5477.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Dehm, K. M. Regan, L. J. Schmidt, and D. J. Tindall
Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion Independent Prostate Cancer Cells
Cancer Res., October 15, 2007; 67(20): 10067 - 10077.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
U. Moehren, M. Papaioannou, C. A. Reeb, W. Hong, and A. Baniahmad
Alien Interacts with the Human Androgen Receptor and Inhibits Prostate Cancer Cell Growth
Mol. Endocrinol., May 1, 2007; 21(5): 1039 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. I. Klokk, P. Kurys, C. Elbi, A. K. Nagaich, A. Hendarwanto, T. Slagsvold, C.-Y. Chang, G. L. Hager, and F. Saatcioglu
Ligand-Specific Dynamics of the Androgen Receptor at Its Response Element in Living Cells
Mol. Cell. Biol., March 1, 2007; 27(5): 1823 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C. J Burd, L. M Morey, and K. E Knudsen
Androgen receptor corepressors and prostate cancer
Endocr. Relat. Cancer, December 1, 2006; 13(4): 979 - 994.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Germain, B. Staels, C. Dacquet, M. Spedding, and V. Laudet
Overview of Nomenclature of Nuclear Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 685 - 704.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Fu, M. Liu, A. A. Sauve, X. Jiao, X. Zhang, X. Wu, M. J. Powell, T. Yang, W. Gu, M. L. Avantaggiati, et al.
Hormonal Control of Androgen Receptor Function through SIRT1
Mol. Cell. Biol., November 1, 2006; 26(21): 8122 - 8135.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Tung, H. Abdel-Hafiz, T. Shen, D. M. E. Harvell, L. K. Nitao, J. K. Richer, C. A. Sartorius, G. S. Takimoto, and K. B. Horwitz
Progesterone Receptors (PR)-B and -A Regulate Transcription by Different Mechanisms: AF-3 Exerts Regulatory Control over Coactivator Binding to PR-B
Mol. Endocrinol., November 1, 2006; 20(11): 2656 - 2670.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Dehm and D. J. Tindall
Ligand-independent Androgen Receptor Activity Is Activation Function-2-independent and Resistant to Antiandrogens in Androgen Refractory Prostate Cancer Cells
J. Biol. Chem., September 22, 2006; 281(38): 27882 - 27893.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Wu, H. Kawate, K. Ohnaka, H. Nawata, and R. Takayanagi
Nuclear Compartmentalization of N-CoR and Its Interactions with Steroid Receptors.
Mol. Cell. Biol., September 1, 2006; 26(17): 6633 - 6655.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Georgiakaki, N. Chabbert-Buffet, B. Dasen, G. Meduri, S. Wenk, L. Rajhi, L. Amazit, A. Chauchereau, C. W. Burger, L. J. Blok, et al.
Ligand-Controlled Interaction of Histone Acetyltransferase Binding to ORC-1 (HBO1) with the N-Terminal Transactivating Domain of Progesterone Receptor Induces Steroid Receptor Coactivator 1-Dependent Coactivation of Transcription
Mol. Endocrinol., September 1, 2006; 20(9): 2122 - 2140.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Tian, M. A. Mahajan, C. T. Wong, I. Habeos, and H. H. Samuels
The N-Terminal A/B Domain of the Thyroid Hormone Receptor-{beta}2 Isoform Influences Ligand-Dependent Recruitment of Coactivators to the Ligand-Binding Domain
Mol. Endocrinol., September 1, 2006; 20(9): 2036 - 2051.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Carascossa, J. Gobinet, V. Georget, A. Lucas, E. Badia, A. Castet, R. White, J.-C. Nicolas, V. Cavailles, and S. Jalaguier
Receptor-Interacting Protein 140 Is a Repressor of the Androgen Receptor Activity
Mol. Endocrinol., July 1, 2006; 20(7): 1506 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. M. Butler, M. M. Centenera, P. J. Neufing, G. Buchanan, C. S. Y. Choong, C. Ricciardelli, K. Saint, M. Lee, A. Ochnik, M. Yang, et al.
Suppression of Androgen Receptor Signaling in Prostate Cancer Cells by an Inhibitory Receptor Variant
Mol. Endocrinol., May 1, 2006; 20(5): 1009 - 1024.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J Jaaskelainen, A Deeb, J W Schwabe, N P Mongan, H Martin, and I A Hughes
Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.
J. Mol. Endocrinol., April 1, 2006; 36(2): 361 - 368.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Li, J. Fu, C. Toumazou, H.-G. Yoon, and J. Wong
A Role of the Amino-Terminal (N) and Carboxyl-Terminal (C) Interaction in Binding of Androgen Receptor to Chromatin
Mol. Endocrinol., April 1, 2006; 20(4): 776 - 785.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Augereau, E. Badia, M. Fuentes, F. Rabenoelina, M. Corniou, D. Derocq, P. Balaguer, and V. Cavailles
Transcriptional Regulation of the Human NRIP1/RIP140 Gene by Estrogen Is Modulated by Dioxin Signalling
Mol. Pharmacol., April 1, 2006; 69(4): 1338 - 1346.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Iwasaki, A. Takeshita, W. Miyazaki, W. W. Chin, and N. Koibuchi
The Interaction of TR{beta}1-N Terminus with Steroid Receptor Coactivator-1 (SRC-1) Serves a Full Transcriptional Activation Function of SRC-1
Endocrinology, March 1, 2006; 147(3): 1452 - 1457.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. H. Kasper, T. Fukuyama, M. A. Biesen, F. Boussouar, C. Tong, A. de Pauw, P. J. Murray, J. M. A. van Deursen, and P. K. Brindle
Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development
Mol. Cell. Biol., February 1, 2006; 26(3): 789 - 809.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Callewaert, N. Van Tilborgh, and F. Claessens
Interplay between Two Hormone-Independent Activation Domains in the Androgen Receptor
Cancer Res., January 1, 2006; 66(1): 543 - 553.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
K-M Rau, H-Y Kang, T-L Cha, S A Miller, and M-C Hung
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers
Endocr. Relat. Cancer, September 1, 2005; 12(3): 511 - 532.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Ye, S. J. Han, S. Y. Tsai, F. J. DeMayo, J. Xu, M.-J. Tsai, and B. W. O'Malley
Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice
PNAS, July 5, 2005; 102(27): 9487 - 9492.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K.-H. Chuang, Y.-F. Lee, W.-J. Lin, C.-Y. Chu, S. Altuwaijri, Y.-J. Y. Wan, and C. Chang
9-cis-Retinoic Acid Inhibits Androgen Receptor Activity through Activation of Retinoid X Receptor
Mol. Endocrinol., May 1, 2005; 19(5): 1200 - 1212.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. L. Mayeur, W.-J. Kung, A. Martinez, C. Izumiya, D. J. Chen, and H.-J. Kung
Ku Is a Novel Transcriptional Recycling Coactivator of the Androgen Receptor in Prostate Cancer Cells
J. Biol. Chem., March 18, 2005; 280(11): 10827 - 10833.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. J. Burd, C. E. Petre, H. Moghadam, E. M. Wilson, and K. E. Knudsen
Cyclin D1 Binding to the Androgen Receptor (AR) NH2-Terminal Domain Inhibits Activation Function 2 Association and Reveals Dual Roles for AR Corepression
Mol. Endocrinol., March 1, 2005; 19(3): 607 - 620.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. C. Hodgson, I. Astapova, S. Cheng, L. J. Lee, M. C. Verhoeven, E. Choi, S. P. Balk, and A. N. Hollenberg
The Androgen Receptor Recruits Nuclear Receptor CoRepressor (N-CoR) in the Presence of Mifepristone via Its N and C Termini Revealing a Novel Molecular Mechanism for Androgen Receptor Antagonists
J. Biol. Chem., February 25, 2005; 280(8): 6511 - 6519.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Cho, B. L. Kagan, J. A. Blackford Jr., D. Szapary, and S. S. Simons Jr.
Glucocorticoid Receptor Ligand Binding Domain Is Sufficient for the Modulation of Glucocorticoid Induction Properties by Homologous Receptors, Coactivator Transcription Intermediary Factor 2, and Ubc9
Mol. Endocrinol., February 1, 2005; 19(2): 290 - 311.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Masiello, S.-Y. Chen, Y. Xu, M. C. Verhoeven, E. Choi, A. N. Hollenberg, and S. P. Balk
Recruitment of {beta}-Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells
Mol. Endocrinol., October 1, 2004; 18(10): 2388 - 2401.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. J. Dubbink, R. Hersmus, C. S. Verma, H. A. G. M. van der Korput, C. A. Berrevoets, J. van Tol, A. C. J. Ziel-van der Made, A. O. Brinkmann, A. C. W. Pike, and J. Trapman
Distinct Recognition Modes of FXXLF and LXXLL Motifs by the Androgen Receptor
Mol. Endocrinol., September 1, 2004; 18(9): 2132 - 2150.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Buchanan, M. Yang, A. Cheong, J. M. Harris, R. A. Irvine, P. F. Lambert, N. L. Moore, M. Raynor, P. J. Neufing, G. A. Coetzee, et al.
Structural and functional consequences of glutamine tract variation in the androgen receptor
Hum. Mol. Genet., August 15, 2004; 13(16): 1677 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Powzaniuk, S. McElwee-Witmer, R. L. Vogel, T. Hayami, S. J. Rutledge, F. Chen, S.-i. Harada, A. Schmidt, G. A. Rodan, L. P. Freedman, et al.
The LATS2/KPM Tumor Suppressor Is a Negative Regulator of the Androgen Receptor
Mol. Endocrinol., August 1, 2004; 18(8): 2011 - 2023.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Merot, R. Metivier, G. Penot, D. Manu, C. Saligaut, F. Gannon, F. Pakdel, O. Kah, and G. Flouriot
The Relative Contribution Exerted by AF-1 and AF-2 Transactivation Functions in Estrogen Receptor {alpha} Transcriptional Activity Depends upon the Differentiation Stage of the Cell
J. Biol. Chem., June 18, 2004; 279(25): 26184 - 26191.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, B. O. Kim, C. Kao, C. Jung, J. T. Dalton, and J. J. He
Tip110, the Human Immunodeficiency Virus Type 1 (HIV-1) Tat-interacting Protein of 110 kDa as a Negative Regulator of Androgen Receptor (AR) Transcriptional Activation
J. Biol. Chem., May 21, 2004; 279(21): 21766 - 21773.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Wang, T. S. Udayakumar, T. S. Vasaitis, A. M. Brodie, and J. D. Fondell
Mechanistic Relationship between Androgen Receptor Polyglutamine Tract Truncation and Androgen-dependent Transcriptional Hyperactivity in Prostate Cancer Cells
J. Biol. Chem., April 23, 2004; 279(17): 17319 - 17328.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Castet, A. Boulahtouf, G. Versini, S. Bonnet, P. Augereau, F. Vignon, S. Khochbin, S. Jalaguier, and V. Cavailles
Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition
Nucleic Acids Res., April 1, 2004; 32(6): 1957 - 1966.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Zhang, Y. Yang, S. Yeh, and C. Chang
ARA67/PAT1 Functions as a Repressor To Suppress Androgen Receptor Transactivation
Mol. Cell. Biol., February 1, 2004; 24(3): 1044 - 1057.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. Borud, G. Mellgren, J. Lund, and M. Bakke
Cloning and Characterization of a Novel Zinc Finger Protein that Modulates the Transcriptional Activity of Nuclear Receptors
Mol. Endocrinol., November 1, 2003; 17(11): 2303 - 2319.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Hosohata, P. Li, Y. Hosohata, J. Qin, R. G. Roeder, and Z. Wang
Purification and Identification of a Novel Complex Which Is Involved in Androgen Receptor-Dependent Transcription
Mol. Cell. Biol., October 1, 2003; 23(19): 7019 - 7029.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Warnmark, E. Treuter, A. P. H. Wright, and J.-A. Gustafsson
Activation Functions 1 and 2 of Nuclear Receptors: Molecular Strategies for Transcriptional Activation
Mol. Endocrinol., October 1, 2003; 17(10): 1901 - 1909.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Ding, J. Yan, J. Zhu, H. Zhong, Q. Lu, Z. Wang, C. Huang, and Q. Ye
Ligand-independent activation of estrogen receptor {alpha} by XBP-1
Nucleic Acids Res., September 15, 2003; 31(18): 5266 - 5274.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. K. Lee and C. Chang
Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4043 - 4054.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Ghali, B. Gottlieb, R. Lumbroso, L. K. Beitel, Y. Elhaji, J. Wu, L. Pinsky, and M. A. Trifiro
The Use of Androgen Receptor Amino/Carboxyl-Terminal Interaction Assays to Investigate Androgen Receptor Gene Mutations in Subjects with Varying Degrees of Androgen Insensitivity
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2185 - 2193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Callewaert, G. Verrijdt, V. Christiaens, A. Haelens, and F. Claessens
Dual Function of an Amino-terminal Amphipatic Helix in Androgen Receptor-mediated Transactivation through Specific and Nonspecific Response Elements
J. Biol. Chem., February 28, 2003; 278(10): 8212 - 8218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Liao, L.-Y. Chen, A. Zhang, A. Godavarthy, F. Xia, J. C. Ghosh, H. Li, and J. D. Chen
Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT
J. Biol. Chem., February 7, 2003; 278(7): 5052 - 5061.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Kumar and E. B. Thompson
Transactivation Functions of the N-Terminal Domains of Nuclear Hormone Receptors: Protein Folding and Coactivator Interactions
Mol. Endocrinol., January 1, 2003; 17(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Christiaens, C. L. Bevan, L. Callewaert, A. Haelens, G. Verrijdt, W. Rombauts, and F. Claessens
Characterization of the Two Coactivator-interacting Surfaces of the Androgen Receptor and Their Relative Role in Transcriptional Control*
J. Biol. Chem., December 13, 2002; 277(51): 49230 - 49237.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Chen, A. Kerimo, S. Khan, and L.-N. Wei
Real-Time Analysis of Molecular Interaction of Retinoid Receptors and Receptor-Interacting Protein 140 (RIP140)
Mol. Endocrinol., November 1, 2002; 16(11): 2528 - 2537.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Wang, D. Sharma, Y. Ren, and J. D. Fondell
A Coregulatory Role for the TRAP-Mediator Complex in Androgen Receptor-mediated Gene Expression
J. Biol. Chem., November 1, 2002; 277(45): 42852 - 42858.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. S. Lee, H.-J. Kim, H. J. Lee, J. W. Lee, S.-Y. Chun, S.-K. Ko, and K. Lee
Activating Signal Cointegrator 1 Is Highly Expressed in Murine Testicular Leydig Cells and Enhances the Ligand-Dependent Transactivation of Androgen Receptor
Biol Reprod, November 1, 2002; 67(5): 1580 - 1587.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Reid, I. Murray, K. Watt, R. Betney, and I. J. McEwan
The Androgen Receptor Interacts with Multiple Regions of the Large Subunit of General Transcription Factor TFIIF
J. Biol. Chem., October 18, 2002; 277(43): 41247 - 41253.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Li, X. Yu, K. Ge, J. Melamed, R. G. Roeder, and Z. Wang
Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer
Am. J. Pathol., October 1, 2002; 161(4): 1467 - 1474.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kaul, P. J. M. Murphy, J. Chen, L. Brown, W. B. Pratt, and S. S. Simons Jr.
Mutations at Positions 547-553 of Rat Glucocorticoid Receptors Reveal That hsp90 Binding Requires the Presence, but Not Defined Composition, of a Seven-amino Acid Sequence at the Amino Terminus of the Ligand Binding Domain
J. Biol. Chem., September 20, 2002; 277(39): 36223 - 36232.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Abdel-Hafiz, G. S. Takimoto, L. Tung, and K. B. Horwitz
The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression
J. Biol. Chem., September 6, 2002; 277(37): 33950 - 33956.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Kotaja, U. Karvonen, O. A. Janne, and J. J. Palvimo
The Nuclear Receptor Interaction Domain of GRIP1 Is Modulated by Covalent Attachment of SUMO-1
J. Biol. Chem., August 9,&